PX1 Research provides high-purity GLP-2TZ as a dedicated research compound for qualified academic, biotechnology, and institutional laboratories. Every production lot undergoes rigorous analytical verification, including RP-HPLC, mass spectrometry, and endotoxin quantification, to ensure uncompromising reproducibility in preclinical assays.
PX1 Research provides high-purity GLP-2TZ as a dedicated research compound for qualified academic, biotechnology, and institutional laboratories. Every production lot undergoes rigorous analytical verification, including RP-HPLC, mass spectrometry, and endotoxin quantification, to ensure uncompromising reproducibility in preclinical assays.
Qualified institutions seeking GLP-2TZ for sale require analytical grade purity, verified lot-to-lot consistency, and complete chemical transparency. GLP-2TZ is a specialized synthetic research peptide engineered to facilitate multi-receptor binding investigations involving the glucagon-like peptide-2 (GLP-2) receptor alongside incretin pathways. Supplied strictly as a lyophilized solid, this peptide is intended exclusively for in vitro experimentation and animal model studies.
When procuring peptides for advanced biochemical assays, laboratory researchers must ensure their samples are free of TFA salts, residual solvents, and bacterial endotoxins. PX1 Research fulfills these requirements by manufacturing compounds in domestic GMP-compliant facilities, providing complete batch documentation, and backing every lot with third-party testing performed by ISO 17025 accredited analytical laboratories. Investigators can explore our complete research peptide catalog to access high-purity reagents for ongoing comparative studies.
GLP-2TZ represents an engineered peptide conjugate or chimeric sequence designed to probe the overlap between gastrointestinal mucosal repair signaling and metabolic receptor pathways. Glucagon-like peptide-2 (GLP-2) is a 33-amino-acid proglucagon-derived peptide primarily secreted by intestinal L-cells. It exerts potent trophic effects on the intestinal epithelium by activating the G-protein coupled GLP-2 receptor (GLP-2R).
In contrast to single-target incretin analogs, GLP-2TZ is designed for experimental setups evaluating multi-receptor cross-talk. Preclinical models indicate that simultaneous activation of GLP-2R alongside glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors may modulate downstream cAMP accumulation, intracellular calcium mobilization, and enterocyte survival signaling pathways. Researchers utilizing GIP and GLP-1 receptor research compounds often incorporate GLP-2TZ to evaluate gut-barrier reinforcement alongside metabolic parameters.
In vitro data indicate that GLP-2 receptor activation initiates an intracellular signal transduction cascade involving adenylyl cyclase activation and increased intracellular cAMP. In primary intestinal epithelial cell cultures, this mechanism correlates with upregulation of tight junction proteins—such as zonula occludens-1 (ZO-1), occludin, and claudin family members—thereby reducing paracellular permeability.
Rodent models of intestinal inflammation and mucosal injury demonstrate that administration of GLP-2 receptor agonists promotes crypt cell proliferation and inhibits enterocyte apoptosis. When evaluated in experimental models of ischemia-reperfusion or chemical colitis, chimeric GLP-2 sequences demonstrate enhanced mucosal mass, increased villus height, and reduced systemic translocation of luminal antigens. Investigators studying gut mucosal architecture can reference our GLP-2 signaling research overview for in-depth biochemical pathways.
To contextualize GLP-2TZ performance within multi-receptor pharmacology, researchers frequently compare its receptor affinity profiles against established single, dual, and triple agonist controls. Unlike mono-agonists that target only a single signaling cascade, multi-target peptides alter metabolic and structural outputs across distinct cell lines simultaneously.
For instance, mono-selective agonists like semaglutide act primarily via the GLP-1 receptor to alter glycemic control and gastric emptying kinetics in animal models. Dual agonists such as tirzepatide combine GLP-1 and GIP signaling to exert synergistic effects on metabolic expenditure. Meanwhile, broader multi-agonists like retatrutide incorporate glucagon receptor activity. GLP-2TZ uniquely bridges this space by integrating GLP-2 sequence elements targeting intestinal integrity directly alongside dual incretin backbones, providing a novel tool for multi-pathway gut-metabolic research.
For laboratory results to be reproducible, research peptides must maintain precise sequence fidelity and high chemical purity. Synthetic peptide synthesis can yield truncation sequences, deletion peptides, and side-chain protecting group adducts if reaction parameters are not tightly controlled. PX1 Research subjects every batch of GLP-2TZ to stringent post-synthesis purification.
Purity is quantified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), which separates target sequences from closely related synthesis impurities. A minimum purity threshold of 99.0% is confirmed by chromatographic peak integration. Furthermore, Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or electrospray ionization (ESI) mass spectrometry is conducted to verify exact molecular mass, ensuring the correct amino acid sequence is present without unexpected post-translational or synthetic modifications.
Bacterial endotoxins (lipopolysaccharides) are common contaminants in synthetic peptide production derived from water systems, processing equipment, or raw reagents. In cell culture models or sensitive animal assays, minute endotoxin concentrations can trigger non-specific inflammatory responses via Toll-like receptor 4 (TLR4) activation, skewing biological measurements and introducing experimental artifacts.
PX1 Research performs Chromogenic Limulus Amebocyte Lysate (LAL) testing on every lot of GLP-2TZ to guarantee endotoxin levels remain below strictly defined laboratory limits (<0.01 EU/μg). This ensures that observed physiological or cellular reactions in preclinical models are directly attributable to GLP-2TZ receptor engagement rather than background pyrogen contamination. Detailed analytical certificates can be reviewed within our public PX1 research library.
GLP-2TZ is supplied as a sterile, lyophylized cake or powder inside high-recovery borosilicate glass vials. To preserve secondary structure and biological activity, reconstitution must follow precise laboratory protocols. Lyophilized peptides should be allowed to equilibrate to room temperature inside a desiccator prior to opening to prevent atmospheric moisture condensation.
Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) for multi-use laboratory procedures or Sterile Water for Injection (SWFI) for single-assay applications. Gentle side-wall swirling is recommended; vortexing or vigorous agitation must be avoided to prevent mechanical shearing and peptide aggregation. For hydrophobic or highly self-aggregating sequences, a small percentage of sterile dilute acetic acid or dimethyl sulfoxide (DMSO) may be utilized as a primary solubilization vector prior to diluting in buffered saline (PBS, pH 7.4).
Lyophilized GLP-2TZ remains stable for up to 24 months when stored at -20°C in a manual defrost freezer protected from light. For long-term archive storage exceeding 12 months, maintaining temperature control at -80°C is recommended to prevent trace hydrolysis or oxidation of vulnerable residues such as methionine or tryptophan.
Once reconstituted into aqueous solution, the peptide reagent should be aliquoted into single-use polypropylene or low-protein-binding microcentrifuge tubes to prevent repeated freeze-thaw cycles. Reconstituted liquid aliquots remain stable at 2°C to 8°C for up to 14 days, or at -20°C for up to 90 days. Repeated thermal cycling drastically accelerates degradation and peptide precipitation, compromising experimental baseline measurements.
Academic laboratories, CROs, and institutional procurement departments requiring consistent high-volume supply can benefit from PX1 Research's standardized distribution framework. We maintain dedicated inventory reserves across our California and Arizona fulfillment centers, guaranteeing standard same-day dispatch for orders confirmed Monday through Friday before cutoff times.
Principal investigators managing multi-phase trial models can secure lot-reserved inventory to maintain single-batch uniformity across multi-month experimental protocols. To submit high-quantity quote requests or configure recurring delivery schedules, procurement officers are encouraged to access our dedicated wholesale laboratory portal.
What is GLP-2TZ and how is it used in research?
GLP-2TZ is a synthetic research compound designed for studying GLP-2 receptor interaction alongside incretin signaling pathways. It is used in laboratory settings to evaluate mucosal repair, tight-junction expression, and receptor binding kinetics.
How does PX1 Research verify the purity of GLP-2TZ?
Every lot of GLP-2TZ is tested by an independent ISO 17025 accredited laboratory using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity quantification (>99%) and Mass Spectrometry (MS) for sequence identity verification.
Are endotoxin levels tested for GLP-2TZ lots?
Yes. Every production batch undergoes Chromogenic LAL assay testing to confirm endotoxin levels are under strict laboratory thresholds (<0.01 EU/μg), ensuring cell culture integrity and minimizing non-specific immune responses in preclinical models.
What diluent should be used to reconstitute GLP-2TZ for laboratory use?
GLP-2TZ should be reconstituted using sterile Bacteriostatic Water or sterile lab-grade water. Gentle swirling should be used to dissolve the powder; vigorous shaking or high-speed vortexing should be avoided to prevent protein aggregation.
Can GLP-2TZ be purchased for personal or clinical use?
No. GLP-2TZ is supplied strictly for in vitro laboratory research and preclinical animal experimentation. It is not intended, labeled, or approved for human consumption, therapeutic use, or clinical administration.
What are the recommended storage temperature parameters for GLP-2TZ?
Lyophilized powder should be stored at -20°C (or -80°C for long-term storage). Reconstituted solution aliquots should be stored at 2°C to 8°C for short-term use (up to 14 days) or frozen at -20°C to avoid freeze-thaw degradation.
Does PX1 Research provide bulk supply options for institutional laboratories?
Yes. PX1 Research offers custom batch sizes, dedicated lot preservation, and institutional pricing through our wholesale lab portal for qualified academic institutions and commercial research facilities.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.